Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ecological and pharmacodynamic effects of MCB3681 on skin, nasal, oropharyngeal and intestinal microbiota.

Next Previous
X
Search
Trial Profile

Ecological and pharmacodynamic effects of MCB3681 on skin, nasal, oropharyngeal and intestinal microbiota.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 29 May 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs DNV 3837 (Primary)
  • Indications Community-acquired pneumonia; Gram-positive infections
  • Focus Adverse reactions

    • Most Recent Events

    • 25 Mar 2021 According to a Deinove media release, results from this trial were presented at the C Diff Foundation annual Conference 2020 in November.
    • 12 Nov 2020 According to a Deinove media release, data will be presented at the C Diff Foundation annual Conference 2020.
    • 12 Sep 2006 New trial record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top